Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Bladder Cancer, including Staging & Grading, in the Context of COVID-19
  • Standard of Care
  • New Treatment Approaches
  • Update on Clinical Trials
  • The Role of Diagnostic Technologies, Genomics & Precision Medicine
  • Targeted Treatments: Predicting Response to Treatment
  • The Emerging Role of Immunotherapy
  • Communicating with Your Health Care Team about Quality-of-Life Concerns
  • Follow-Up Care Appointments & Plans
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Nutrition & Hydration Concerns & Tips
  • Questions for Our Panel of Experts

Our Panel of Experts


Gary D. Steinberg, MD

Professor, Department of Urology at NYU Grossman School of Medicine, Director Urology Bladder Cancer Program, Urologist and Surgical Oncologist, NYU Langone Health, Immediate Past Chairperson of the BCAN Scientific Advisory Board


Walter Stadler, MD

Fred C. Buffett Professor, Dean for Clinical Research, Senior Advisor, Cancer Center Director, University of Chicago


Vadim Koshkin, MD

Genitourinary Medical Oncologist, Assistant Professor, Medicine, School of Medicine, University of California San Francisco


Diana L. Bearden, MS, RD, CSO, LD, CNSC

Oncology Dietitian, Michael E. DeBakey VA Medical Center


Stephanie Chisolm, PhD

Director of Education and Advocacy, Bladder Cancer Advocacy Network (BCAN)


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on August 17, 2022.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.